David Joseph Topper

David Joseph Topper is a declared insider at 2 companies; the most frequent names are Arcutis Biotherapeutics, Inc. and Engility Holdings, Inc. Over a trading history stretching from 14 January 2019 to 2 April 2025, the count stands at 6 filings.

Sales make up the whole of the open-market record (2 sales, €238k). Outside the open market, there are 3 share grants. So far in 2025, the count stands at no purchases and 1 sale.

The latest filing, published on 3 April 2025, reports an open-market sale of €139k in Arcutis Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.